NO20054243L - Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat - Google Patents

Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat

Info

Publication number
NO20054243L
NO20054243L NO20054243A NO20054243A NO20054243L NO 20054243 L NO20054243 L NO 20054243L NO 20054243 A NO20054243 A NO 20054243A NO 20054243 A NO20054243 A NO 20054243A NO 20054243 L NO20054243 L NO 20054243L
Authority
NO
Norway
Prior art keywords
deoxypeganine
mecamylamine
treatment
ntbc
abbreviation
Prior art date
Application number
NO20054243A
Other languages
English (en)
Norwegian (no)
Inventor
Klaus Opitz
Joachim Moormann
Hilke Winterhoff
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20054243L publication Critical patent/NO20054243L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
NO20054243A 2003-04-25 2005-09-13 Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat NO20054243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318714A DE10318714B4 (de) 2003-04-25 2003-04-25 Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches
PCT/EP2004/004033 WO2004096200A1 (de) 2003-04-25 2004-04-16 Kombination aus desoxypeganin und mecamylamin zur behandlung des alkoholmissbrauches

Publications (1)

Publication Number Publication Date
NO20054243L true NO20054243L (no) 2005-09-13

Family

ID=33304936

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054243A NO20054243L (no) 2003-04-25 2005-09-13 Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat

Country Status (18)

Country Link
US (1) US20060199866A1 (ko)
EP (1) EP1617831A1 (ko)
JP (1) JP2006524647A (ko)
KR (1) KR20060006946A (ko)
CN (1) CN1771029A (ko)
AR (1) AR044067A1 (ko)
AU (1) AU2004233564A1 (ko)
BR (1) BRPI0410507A (ko)
CA (1) CA2523331A1 (ko)
CL (1) CL2004000881A1 (ko)
DE (1) DE10318714B4 (ko)
EA (1) EA200501514A1 (ko)
MX (1) MXPA05011249A (ko)
MY (1) MY136408A (ko)
NO (1) NO20054243L (ko)
TW (1) TW200427452A (ko)
WO (1) WO2004096200A1 (ko)
ZA (1) ZA200507213B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008045641A2 (en) * 2006-10-10 2008-04-17 The University Of Chicago Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent
CN108498493A (zh) * 2017-02-27 2018-09-07 中国人民解放军第二军医大学 美加明防治晕动症或眩晕症的医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
DE3843239C1 (ko) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
AU750808B2 (en) * 1997-10-03 2002-07-25 Cary Medical Corporation Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug
DE69939498D1 (de) * 1998-12-16 2008-10-16 Univ South Florida Exo-S-Mecamylamin-Formulierung
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Also Published As

Publication number Publication date
DE10318714B4 (de) 2006-03-23
CN1771029A (zh) 2006-05-10
AR044067A1 (es) 2005-08-24
KR20060006946A (ko) 2006-01-20
EP1617831A1 (de) 2006-01-25
US20060199866A1 (en) 2006-09-07
CL2004000881A1 (es) 2005-01-21
JP2006524647A (ja) 2006-11-02
CA2523331A1 (en) 2004-11-11
BRPI0410507A (pt) 2006-06-20
AU2004233564A1 (en) 2004-11-11
ZA200507213B (en) 2006-05-31
MXPA05011249A (es) 2005-12-14
TW200427452A (en) 2004-12-16
EA200501514A1 (ru) 2006-04-28
MY136408A (en) 2008-09-30
WO2004096200A1 (de) 2004-11-11
DE10318714A1 (de) 2004-11-18

Similar Documents

Publication Publication Date Title
Rosenstock et al. Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add‐on to metformin in type 2 diabetes with mild hyperglycaemia
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
WO2008146178A3 (en) A novel tablet dosage form
CU23367A3 (es) Formulación de moxifloxacino con sal común
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
NO20044487L (no) Kombinasjon av organiske forbindelser
UA102254C2 (ru) Жидкий состав для деферипрона с приятным вкусом
NO20060651L (no) Fremgangsmate for behandling av virale infeksjoner
NO20052408L (no) Farmasoytisk formulering av olanzapin
WO2004105485A3 (en) Inducible release vehicles
EA200601901A1 (ru) Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
DK1414467T3 (da) Topisk behandling af mastalgi
NO20054243L (no) Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
WO2004071402A3 (en) STABLE PHARMACEUTICAL DOSAGE FORM COMPRISING HMG-CoA REDUCTASE INHIBITOR
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
NO20054320L (no) Terapeutisk middel mot hemoroidesykdom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application